J
Julie E. Horowitz
Researcher at Regeneron
Publications - 9
Citations - 299
Julie E. Horowitz is an academic researcher from Regeneron. The author has contributed to research in topics: Placebo & Population. The author has an hindex of 6, co-authored 9 publications receiving 96 citations.
Papers
More filters
Journal ArticleDOI
Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated with Monogenic Variants, Identified by Whole-exome Sequencing in 1000 Children at a Single Center
Eileen Crowley,Eileen Crowley,Neil Warner,Jie Pan,Sam Khalouei,Abdul Elkadri,Karoline Fiedler,Justin Foong,Andrei L. Turinsky,Dana M. Bronte-Tinkew,Shiqi Zhang,Jamie Hu,David Tian,Dalin Li,Julie E. Horowitz,Iram Siddiqui,Julia Upton,Chaim M. Roifman,Peter C Church,Donna A. Wall,Arun K. Ramani,Daniel Kotlarz,Christoph Klein,Holm H. Uhlig,Scott B. Snapper,Scott B. Snapper,Claudia Gonzaga-Jauregui,Andrew D. Paterson,Dermot P.B. McGovern,Michael Brudno,Thomas D. Walters,Anne M. Griffiths,Aleixo M. Muise +32 more
TL;DR: Monogenic IBD is rare but should be considered in analysis of all patients with pediatric onset of IBD, and 1% of the patients had variants that could be potentially corrected with allogeneic hematopoietic stem cell transplantation.
Journal ArticleDOI
Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals
Jack A. Kosmicki,Julie E. Horowitz,Nilanjana Banerjee,Rouel Lanche,Anthony Marcketta,Evan Maxwell,Xiaodong Bai,Dylan Sun,Joshua D. Backman,Deepika Sharma,F. S. P. Kury,Hyun Min Kang,Colm O'Dushlaine,Ashish Yadav,Adam J. Mansfield,Alexander H. Li,Kyoko Watanabe,Lauren Gurski,Shane McCarthy,Adam E. Locke,Shareef Khalid,Sean O'Keeffe,Joelle Mbatchou,Olympe Chazara,Yunfeng Huang,Erika Kvikstad,A. O'Neill,Paul Nioi,Margaret M. Parker,Slavé Petrovski,Heiko Runz,Joseph D. Szustakowski,Quanli Wang,Emily Wong,A. Cordova-Palomera,E. N. Smith,Sándor Szalma,Xiuwen Zheng,Sahar Esmaeeli,Justin W. Davis,Yi-Pin Lai,Xing Chen,Anne E. Justice,Joseph B. Leader,Tooraj Mirshahi,David J. Carey,Anurag Verma,Giorgio Sirugo,Marylyn D. Ritchie,Daniel J. Rader,Gundula Povysil,David Goldstein,Krzysztof Kiryluk,Erola Pairo-Castineira,Konrad Rawlik,Dorota Pasko,Susan P. Walker,Alison M. Meynert,Athanasios Kousathanas,Loukas Moutsianas,Albert Tenesa,Mark J. Caulfield,Richard H Scott,James F. Wilson,J. K. Baillie,Guillaume Butler-Laporte,Tomoko Nakanishi,Mark Lathrop,J. B. Richards,Martin I. Jones,Suganthi Balasubramanian,Will Salerno,A. R. Shuldiner,Jonathan Marchini,John D. Overton,Lukas Habegger,Michael N. Cantor,Jeffrey G. Reid,A. Baras,Gonçalo R. Abecasis,Manuel A. R. Ferreira +80 more
TL;DR: In this article, the authors used exome sequence data to investigate associations between rare genetic variants and seven COVID-19 outcomes in 586,157 individuals, including 20,952 with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a respiratory illness causing hospitalization or death.
Journal ArticleDOI
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.
Klaus F. Rabe,Bartolome R. Celli,Michael E. Wechsler,Raolat M Abdulai,Xiaodong Luo,Maarten M Boomsma,Heribert Staudinger,Julie E. Horowitz,Aris Baras,Manuel A. R. Ferreira,Marcella Ruddy,Michael C Nivens,Nikhil Amin,David M. Weinreich,George D. Yancopoulos,Helene Goulaouic +15 more
TL;DR: Itepekimab, a monoclonal antibody targeting IL-33, demonstrated clinical activity in asthma, with potential in chronic obstructive pulmonary disease (COPD).
Posted ContentDOI
Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease
Julie E. Horowitz,Jack A. Kosmicki,Amy Damask,Deepika Sharma,Genevieve H.L. Roberts,Anne E. Justice,Nilanjana Banerjee,Marie V. Coignet,Ashish Yadav,Joseph B. Leader,Anthony Marcketta,Danny S. Park,Rouel Lanche,Evan Maxwell,Spencer C. Knight,Xiaodong Bai,Harenda Guturu,Dylan Sun,Asher K. Haug Baltzell,Fabricio S. P. Kury,Joshua D. Backman,Ahna R. Girshick,Colm O'Dushlaine,Shannon R. McCurdy,Raghavendran Partha,Adam J. Mansfield,David A. Turissini,Alexander H. Li,Miao Zhang,Joelle Mbatchou,Kyoko Watanabe,Lauren Gurski,Shane McCarthy,Hyun Min Kang,Lee Dobbyn,Eli A. Stahl,Anurag Verma,Giorgio Sirugo,Marylyn D. Ritchie,Marcus B. Jones,Suganthi Balasubramanian,Katherine A. Siminovitch,William J Salerno,Alan R. Shuldiner,Daniel J. Rader,Tooraj Mirshahi,Adam E. Locke,Jonathan Marchini,John D. Overton,David J. Carey,Lukas Habegger,Michael N. Cantor,Kristin A. Rand,Eurie L. Hong,Jeffrey G. Reid,Catherine A. Ball,Aris Baras,Gonçalo R. Abecasis,Manuel A. R. Ferreira +58 more
TL;DR: Seven common genetic variants that modulate COVID-19 susceptibility and severity are identified, implicating IFNAR2, CCHCR1, TCF19, SLC6A20 and the hyaluronan pathway as potential therapeutic targets.
Posted ContentDOI
Genetic association analysis of SARS-CoV-2 infection in 455,838 UK Biobank participants
Jack A. Kosmicki,Julie E. Horowitz,Nilanjana Banerjee,Rouel Lanche,Anthony Marcketta,Evan Maxwell,Xiaodong Bai,Dylan Sun,Joshua D. Backman,Deepika Sharma,Hyun Min Kang,Colm O'Dushlaine,Ashish Yadav,Adam J. Mansfield,Alexander H. Li,Kyoko Watanabe,Lauren Gurski,Shane McCarthy,Adam E. Locke,Shareef Khalid,Sean O'Keeffe,Joelle Mbatchou,Olympe Chazara,Yunfeng Huang,Erika Kvikstad,Amanda O'Neill,Paul Nioi,Margaret M. Parker,Slavé Petrovski,Heiko Runz,Joseph D. Szustakowski,Quanli Wang,Emily Wong,Aldo Cordova-Palomera,E. N. Smith,Sándor Szalma,Xiuwen Zheng,Sahar Esmaeli,Justin W. Davis,Yi-Pin Lai,Xing Chen,Anne E. Justice,Joseph B. Leader,Tooraj Mirshahi,David J. Carey,Anurag Verma,Marylyn D. Ritchie,Giorgio Sirugo,Daniel J. Rader,Gundula Povysil,David Goldstein,Krzysztof Kiryluk,Erola Pairo-Castineira,Erola Pairo-Castineira,Konrad Rawlik,Dorota Pasko,Susan P. Walker,Alison M. Meynert,Athanasios Kousathanas,Loukas Moutsianas,Albert Tenesa,Albert Tenesa,Mark J. Caulfield,Richard H Scott,James F. Wilson,J Kenneth Baillie,J Kenneth Baillie,Guillaume Butler-Laporte,Guillaume Butler-Laporte,Tomoko Nakanishi,Mark Lathrop,J. Brent Richards,Marcus B. Jones,Suganthi Balasubramanian,William J Salerno,Alan R. Shuldiner,Jonathan Marchini,John D. Overton,Lukas Habegger,Michael N. Cantor,Jeffrey S. Reid,Aris Baras,Gonçalo R. Abecasis,Manuel A. R. Ferreira +83 more
TL;DR: The authors' analyses corroborate the association with the 3p21.31 locus and highlight that there are no rare protein-coding variant associations with effect sizes detectable at current sample sizes, as well as identifying two loci associated with risk of infection at P<5x10-8.